top of page
India’s first CAR-T cell therapy is helping patients battle cancer

For more details

LinkedIn
etlogo (1).jpg

Latest News

Image by Drew Beamer

Our trailblazing NexCAR19, India’s first Market Approved CAR-T cell therapy, has bagged the #ETREPharmaAwards! A testament to our fruitful collaboration with IIT Bombay and Tata Memorial Centre

January 20, 2024 

The Economics Times

Image by Drew Beamer

Our work was recently highlighted by Ben Johnson and Nature Biotech's editorial team, in indigenising innovation to improve affordability & accessibility of CAR-T cell therapies as evidenced with the now commercially available NexCAR19 (Actalycabtagene autoleucel)

January 20, 2024

Nature Biotechnology

Image by Drew Beamer

Sahyadri Hospitals, Pune have entered in to a partnership with ImmunoACT for administering CAR-T cell therapies, beginning with NexCAR19™ (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia

The Indian Express

January 16, 2024

Image by Drew Beamer

P. D. Hinduja Hospital, Khar has partnered with ImmunoACT, to provide access to NexCAR19 (Actalycabtagene autoleucel) for its patients in a commercial setting.

January 19, 2024

Healthcareradius

Image by Drew Beamer

Fortis Healthcare announces a collaboration with ImmunoACT, under this collaboration, Fortis Healthcare will provide this potentially life-saving autologous therapy at its extensive network of Bone Marrow Transplant centres in Delhi, Gurgaon, Noida, Mumbai, Bengaluru, and Mohali,

January 9, 2024

LinkedIN

Image by Drew Beamer

IIT Bombay Director Prof. Subhasis Chaudhuri and Prof. Rahul Purwar had a meeting with the Hon'ble President of India to invite her to campus and to dedicate the CAR-T cell therapy, developed at IIT Bombay, for Cancer treatment to the nation.

January 5, 2024

IIT Bombay

Image by Drew Beamer

Max Healthcare announces a collaboration with ImmunoACT, to herald the start of its commercial CAR-T cell therapy program

December 5, 2023

The Economics Times

Image by Drew Beamer

ImmunoACT gets CDSCO approval for India's first CAR-T cell therapy for blood cancer

October 13, 2023

The Economics Times

Image by Drew Beamer

Breakthrough cancer treatment to be available in India 1st time as CAR-T cell therapy gets DCGI nod

October 13, 2023

The Print

Image by Drew Beamer

IIT-B startup ImmunoACT's “affordable” blood cancer therapy 

gets regulatory approval - a first for India's CAR-T cell therapy

October 14, 2023

Times of India

Image by Drew Beamer

CDSCO approves ImmunoACT’s CAR-T cell therapy 

June 30, 2023

The Hindu

Image by Drew Beamer

The Mexican government has partnered with ImmunoAct, an IIT Bombay-incubated company which is developing cutting-edge CAR -T cell

March 08, 2023

The Economics Times

Image by Drew Beamer

​​​Tata Memorial Centre and ImmunoACT have entered a strategic partnership with the vision to make India a leading center for the cutting-edge Cell and Gene based therapies

July 07, 2023

LinkedIn

Image by Drew Beamer

Indigenous CAR T Therapy to be soon available in India

September 22, 2022

Money Control

Image by Drew Beamer

Gene therapy to cure leukemia at one-tenth global costs

June 12, 2022

Hindustan Times

Image by Drew Beamer

Homegrown CAR-T cells 'cure' 8-year-old's leukemia

October 23, 2022

The Times of India

Image by Drew Beamer

ImmunoACT Advances Plans For Cut-Price CAR-T In India

June 30, 2022

Pharma Intelligence

Image by Drew Beamer

Indigenous CAR T Therapy to be soon available in India

June 14, 2022

The Pharma Letter

Image by Drew Beamer

Gene therapy to cure leukemia at one-tenth global costs

June 12, 2022

Business Standard

Image by Drew Beamer

ImmunoACT sets up a state-of-art facility for its Phase 2/3 CAR T cell therapy trials

June 14, 2022

The Hindu Business Line

Image by Drew Beamer

Afforbable CAR T Therapy - Interview of ImmunoACT founder

June 13, 2022

Moneycontrol

Image by Drew Beamer

IIT Bombay incubated company provides ray of hope for blood cancers in India

June 12, 2022

Moneycontrol

Image by Drew Beamer

Laurus Labs to buy 26% in CAR T-cell therapy company

November 20, 2021

The Economic Times

Image by Drew Beamer

Tata Memorial Hospital, IIT Bombay Collaborate for ‘First in India’ CAR-T Cell Therapy for Cancer Treatment

June 10, 2021

Gadgets 360: An NDTV initiative

Image by Drew Beamer

Boost for Cancer Care in India: Tata Memorial Hospital, IIT Bombay Conduct First CAR-T Cell Therapy in Early Phase Pilot Clinical Trial

June 09, 2021

eHEALTH

Image by Drew Beamer

India's first CAR-T cell therapy conducted at ACTREC, Tata Hospital in Mumbai

June 09, 2021

Outlook India

Image by Drew Beamer

Tata Memorial Hospital conducts first CAR-T cell therapy

June 08, 2021

Biospectrum

News
Image by Drew Beamer

Department of Biotechnology supported First CAR-T cell therapy conducted at ACTREC, Tata Hospital in Mumbai

June 08, 2021

DBT-BIRAC

Image by Drew Beamer

Cutting edge cancer therapy developed in India. The Hindu, 08 June 2021

June 08, 2021

The Hindu

Image by Drew Beamer

CAR T-cell therapy trials for cancer treatment begin in Mumbai

June 07, 2021

Hindustan Times

Image by Drew Beamer

Clinical trial of CAR T technology to treat blood cancer to begin soon

June 14, 2020

Hindustan Times

Image by Drew Beamer

IIT-B makes a breakthrough in CAR T-cell therapy to help cancer patients

December 13, 2019

Firstpost

Image by Drew Beamer

IIT-Bombay scientists now develop cheaper tech to cure cancer

December 12, 2019

Times of India

Image by Drew Beamer

Cut-price CAR-T cell therapies top India’s biotech agenda

December 03, 2019

Nature Biotechnology

Image by Drew Beamer

100 doctors set up Immuno-Oncological Society to frame treament norms

February 25, 2018

Times of India

bottom of page